GeneDx CFO’s June 9 Stock Surge Signals Executive Confidence Amid Precision‑Medicine Push
GeneDx CFO’s recent insider buying signals confidence in its AI‑driven precision‑medicine strategy, hinting at potential upside amid current volatility.
3 minutes to read